T. Thorsen et al., BUBBLE-INDUCED AGGREGATION OF PLATELETS - EFFECTS OF GAS SPECIES, PROTEINS, AND DECOMPRESSION, Undersea & hyperbaric medicine, 20(2), 1993, pp. 101-119
Citations number
41
Categorie Soggetti
Medicine Miscellaneus","Marine & Freshwater Biology
We show that bubbles containing different gases (N2, He, Ne, Ar, or an
O2-CO2-N2 mixture) are equally potent platelet agonists. The synergis
tic effect of different platelet antagonists does not seem to be affec
ted by the type of gas in the bubbles. In contrast to aggregation in p
latelet-rich plasma (PRP), bubbles cause only a weak response in gel-f
iltered platelets (GFP), i.e., comparison of aggregation in protein-ri
ch and protein-poor platelet suspensions may shed light on the role of
different plasma proteins. Extracellular fibrinogen promotes bubble-i
nduced platelet aggregation similar to known physiologic agonists, whe
reas albumin counteracts this aggregation. Bubble-induced aggregation
is inhibited in GFP-fibrinogen by 2-deoxy-D-glucose plus antimycin A,
suggesting dependency on ATP generation in the platelets and evidence
for direct exposure of the ''cryptic'' fibrinogen receptor by bubbles.
Hyperbaric compression and subsequent rapid, inadequate decompression
of PRP caused little change in the aggregation response to gas bubble
s and epinephrine at 1 bar, but reduced the response to ADP. Bubbles t
ended not to form before the surface film was broken. Pressure-induced
aggregation was apparently metabolically active and not due to passiv
e agglutination; electron microscopic studies and PRP with added gluta
raldehyde did not show platelet activation, clumping, or reduced plate
let count. In contrast to aggregation caused by pressure, bubble-induc
ed aggregation in PRP at 1 bar (after treatment in the pressure chambe
r) was nearly completely inhibited by theophylline, a phosphodiesteras
e inhibitor that increases intracellular platelet cyclic AMP.